# US 2013/0152309 A1 · Antibacterial wound dressing

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0152309 A1
- Document ID: US20130152309A1
- Status: Published application
- Kind: A1
- Application number: 13/767,713
- Filed: 2013-02-14
- Published: 2013-06-20
- Earliest claimed: 2001-09-12
- Assignees: Convatec Technologies Inc.
- Inventors: Roger BRAY
- Web page: https://patentgrep.com/patent/US20130152309A1

## CPC

- A61L 15/28: Polysaccharides or their derivatives {(A61L15/225 takes precedence)}
- A61L 15/18: containing inorganic materials
- A61L 15/44: Medicaments
- A61L 15/46: Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
- A61L 2300/104: Silver, e.g. silver sulfadiazine
- A61L 2300/404: Biocides, antimicrobial agents, antiseptic agents
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)

## Abstract

An antibacterial wound dressing is based on or derived from gel-forming fibres such as carboxymethyl cellulose or alginate fibres having silver ions linked thereto at some but not all of the exchangeable sites such that the distribution of silver ions over the exchangeable sites is substantially uniform. The silvered fibres for the wound dressing can be prepared by contacting an assembly of precursor gel-forming fibres having exchangeable sites under conditions which do not cause irreversible gelling of the fibres with an amount of a solution containing silver ions so as to link silver ions at some but not all of the exchangeable sites, the whole of the assembly of precursor gel-forming fibres being contacted essentially simultaneously with the entire solution containing silver ions.

## Claims

### Claim 1

An antibacterial wound dressing derived from gel-forming fibres having silver ions linked to not more than about 20% of the exchangeable sites on the gel-forming fibres, wherein the distribution of silver ions over the exchangeable sites is essentially uniform as shown by the uniform coloration of the dressing.

### Claim 2 (depends on 1)

An antibacterial wound dressing according to claim 1, wherein the silver ions are linked to not more than 10% of the exchangeable sites on the gel-forming fibres.

### Claim 3 (depends on 1)

An antibacterial wound dressing according to claim 1, wherein the gel forming fibres comprises lyocell-derived fibres.

### Claim 4 (depends on 1)

An antibacterial wound dressing according to claim 1, wherein the gel-forming fibres comprises carboxymethylated cellulose fibres.

### Claim 5 (depends on 1)

An antibacterial wound dressing according to claim 1, wherein the gel-forming fibres comprises calcium alginate or sodium/calcium alginate fibres

### Claim 6 (depends on 1)

An antibacterial wound dressing according to claim 1, wherein the silver content of the silvered fibres is from 0.01 to 10% by weight.

### Claim 7 (depends on 1)

An antibacterial wound dressing according to claim 1, wherein the silver content of the silvered fibres is from 0.1 to 5% by weight.

### Claim 8 (depends on 1)

An antibacterial wound dressing according to claim 1, wherein the silver content of the silvered fibres is from 0.5 to 2% by weight.

### Claim 9 (depends on 1)

An antibacterial wound dressing according to claim 1, wherein the silver content of the silvered fibres is from 0.9 to 1.5% by weight.

### Claim 10 (depends on 1)

An antibacterial wound dressing according to claim 1, wherein the antibacterial wound dressing is photostable.

### Claim 11 (depends on 10)

An antibacterial wound dressing of claim 10, wherein the wound dressing is treated with a metal halide.

### Claim 12 (depends on 11)

An antibacterial wound dressing of claim 11, wherein the metal halide is sodium chloride.

### Claim 13

A process for producing silvered fibres for use in antibacterial wound dressings including the steps of
(i) forming an assembly of precursor gel-forming fibres having thereon exchangeable sites capable of exchange with silver ions to link silver ions to the fibre, and
(ii) essentially simultaneously contacting the assembly of precursor gel-forming fibres with a solution containing silver ions under conditions which do not cause irreversible gelling of the fibres, thereby to link silver ions at exchangeable sites, in which process the whole of the assembly of precursor gel-forming fibres is contacted essentially simultaneously with the entire solution containing silver ions, rather than being contacted gradually or partially, the solution containing silver ions being used in an amount such that enough silver ions are present to link with not more than about 20% of the exchangeable sites on the precursor gel-forming fibres, wherein the distribution of silver ions over the exchangeable sites is essentially uniform as shown by the essentially uniform coloration of the dressing.

### Claim 14 (depends on 13)

A process according to claim 13, wherein the silver ions are not linked with not more than about 10% of the exchangeable sites on the gel-forming fibres.

### Claim 15 (depends on 13)

A process according to claim 13, wherein the precursor gel-forming fibres comprises lyocell-derived fibres.

### Claim 16 (depends on 13)

A process according to claim 13, wherein the precursor gel-forming fibres comprises carboxymethylated cellulose fibres.

### Claim 17 (depends on 13)

A process according to claim 13, wherein the precursor gel-forming fibres comprises calcium alginate or sodium-calcium alginate fibres.

### Claim 18 (depends on 13)

A process according to claim 13, wherein the assembly of silvered, gel-forming fibres is further processed to form wound dressings.

### Claim 18 (depends on 1)

A process according to claim 1, wherein the wound dressings are photostable.

### Claim 19 (depends on 18)

A process according to claim 18, wherein the wound dressings are treated with a metal halide.

### Claim 20 (depends on 18)

A process according to claim 18, wherein the metal halide is sodium chloride.

### Claim 21 (depends on 13)

A process according to claim 13, wherein the silver content of the silvered fibres is from 0.01 to 10% by weight.

### Claim 22 (depends on 13)

A process according to claim 13, wherein the silver content of the silvered fibres is from 0.1 to 5% by weight.

### Claim 23 (depends on 13)

A process according to claim 13, wherein the silver content of the silvered fibres is from 0.5 to 2% by weight.

### Claim 24 (depends on 13)

A process according to claim 13, wherein the silver content of the silvered fibres is from 0.9 to 1.5% by weight.

### Claim 25 (depends on 13)

A process according to claim 13, wherein the silver content of the solution is between 0.1 to 1.0% w/v.

### Claim 26 (depends on 13)

A process according to claim 13, wherein the silver content of the solution is between 0.25 to 0.5% w/v.

### Claim 27 (depends on 13)

A process according to claim 13, wherein the silver content of the solution is 0.35% w/v.

### Claim 28 (depends on 13)

A process according to claim 13, in which the process is a batch process wherein the assembly of precursor gel-forming fibres is contacted with the solution containing silver ions by dipping it rapidly and entirely into the solution.

### Claim 29 (depends on 28)

A process according to claim 28, wherein the solution is held in a container and is an amount required completely to cover the precursor gel-forming fibres so that the fibres fill the solution within the container.

### Claim 30 (depends on 28)

A process according to claim 28, wherein the time interval between the beginning of the dipping of the assembly of precursor gel-forming fibres to form the wound dressing into the solution and the moment at which the assembly of precursor gel-forming fibres to form the wound dressing is entirely dipped into the solution is not more than about 10 seconds.

### Claim 31 (depends on 30)

A process according to claim 30, wherein said time interval is not more than 5 seconds.

### Claim 32 (depends on 28)

A process according to claim 28, wherein the assembly of precursor gel-forming fibres to be dipped is dry.

### Claim 33 (depends on 29)

A process according to claim 29, wherein the solution containing silver ions is held in a closed container.

### Claim 34 (depends on 29)

A process according to claim 29, wherein the solution containing silver ions is held in an open container.
